DISCOUNT ZERTIFIKAT - NOVO NORDISK ADR B Share Price

Certificat

DE000ME79EP6

Real-time Bid/Ask 09:41:49 03/07/2024 pm IST
100.21 EUR / 100.24 EUR -0.82% Intraday chart for DISCOUNT ZERTIFIKAT - NOVO NORDISK ADR B
Current month-0.20%
1 month+2.14%
Date Price Change
03/24/03 100.2 -0.86%
02/24/02 101 -0.13%
01/24/01 101.2 -0.07%
28/24/28 101.2 +0.02%
27/24/27 101.2 -0.21%

Delayed Quote Börse Stuttgart

Last update July 03, 2024 at 08:54 pm IST

More quotes

Static data

Product typeCertificats Discount
Buy / SellCALL
Underlying NOVO NORDISK A/S
Issuer Morgan Stanley
WKN ME79EP
ISINDE000ME79EP6
Date issued 22/01/2024
Cap 110 $
Last trading day 20/09/2024
Maturity 20/09/2024 (79 Days)
Parity 1 : 1
Emission price 90.45
Emission volume N/A
Payment day 27/09/2024
Bonus-
Settlement règlement en espèces
Currency EUR

Technical Indicators

Discount (ask) 21.51 %
Sideways yield 1.654 %
Sideways yield pa 7.640 %
Outperformance point 140.2 $
Break even 108.21 €
Highest since issue 101.4
Lowest since issue 86.89
Spread 0.06
Spread %0.06%
Distance Cap 27.13 $
Distance Cap %+19.78%
Max. earning 1.657
Max. earning % 1.654 %

Company Profile

Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (92.6%); - rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
More about the company

Ratings for Novo Nordisk A/S

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Consensus: Novo Nordisk A/S

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
993.5 DKK
Average target price
952.2 DKK
Spread / Average Target
-4.16%
Consensus